Member News

Awards for Regev and Gierasch; new job for Brenner

ASBMB Today Staff
By ASBMB Today Staff
July 20, 2020

Regev wins Lurie prize

Aviv Regev, the departing chair of the faculty and a core member at the Broad Institute of the Massachusetts Institute for Technology and Harvard University, has won the Foundation for the National Institutes of Health’s 2020 Lurie Prize in Biomedical Sciences. Earlier this year, she announced she will be leaving the Broad to become Genentech’s research and early development chief in August.

Aviv Regev is leaving the Broad Institute to become Genentech’s research and early development chief in August. She also will be a member of the executive committee for Roche, Genentech’s parent company. Read more.

Established in 2013, the Lurie Prize recognizes outstanding achievement by a promising scientist who 52 years old or younger. The prize includes a $100,000 honorarium, made possible by a donation to the FNIH by philanthropist Ann Lurie, president of the Ann and Robert H. Lurie Foundation.

Regev's laboratory at the Broad Institute, MIT and the Howard Hughes Medical Institute studies how complex molecular circuits function in cells and between cells in tissues. The award recognizes her work in laying the groundwork for the field of single-cell genomics, spearheading leading-edge technologies that enable a sharper perspective on human cells and applying them to revolutionize understanding of biology and disease.

“Her innovative work has made a major contribution to scientific understanding, highlighting an astonishing diversity in the activities and types of cells,” said Maria C. Freire, president and executive director of the FNIH. “Applying those revolutionary techniques to cataloguing every cell in the body promises to have a vital impact on the future of diagnosis and therapy.”

Regev won the American Society for Biochemistry and Molecular Biology's Earl and Thressa Stadtman Young Scholar Award in 2014. Read our profile of her.

Gierasch wins Outstanding Achievement Award for research

Lila Gierasch is the editor-in-chief of the ASBMB's Journal of Biological Chemistry. Read our Q&A with her about her work at JBC.

Lila Gierasch, a distinguished professor of biochemistry and molecular biology at the University of Massachusetts Amherst and editor-in-chief of the Journal of Biological Chemistry, was one of two scientists recognized with the UMass College of Natural Science Outstanding Achievement Award in research.

The award recognizes the college’s faculty, staff and students who have made important contributions to their disciplines, departments, college and university.

Gierasch, a 1986 Guggenheim fellow and member of the National Academy of Sciences, is known for her work focused on protein folding and chaperone function in vitro and in vivo.

She won the ASBMB's Mildred Cohn Award in Biological Sciences in 2014. Read our profile of her.

Brenner moving to City of Hope

Charles Brenner will be moving to the City of Hope National Medical Center in Southern California to chair its new department of diabetes and cancer metabolism.

Brenner, a former chair of the American Society for Biochemistry and Molecular Bioogy's Publications Committee, former chair of the editorial advisory board of ASBMB Today and the 2016 winner of the ASBMB Award for Exemplary Contributions to Education, currently serves as the Roy J. Carver chair and head of biochemistry at the University of Iowa.

During his 11 years at Iowa, he hired eight faculty members into the department and oversaw the creation of the university's high-throughput screening facility and the trans-collegiate, trans-disciplinary Obesity Research & Education Initiative.

Brenner is among the world’s experts in NAD metabolism and developed quantitative targeted NAD metabolomics. He has discovered many conditions in which the NAD system is disturbed at the transcriptional and metabolomic levels by metabolic disturbances.

At City of Hope, he plans to expand his program on genotype-specific approaches to cancer, to dissect the systems biology of NAD (i.e., to determine how particular tissues distribute NAD precursors to other tissues, especially as a function of metabolic disruption). He also aims to utilize what has been learned about the activities of nicotinamide riboside in the context of diabetic and chemotherapeutic neuropathy, fatty liver, postpartum, and viral infection to improve human health.

“The fit between what I do in NAD biology and what City of Hope wants in this unit is outstanding,” Brenner said. “In addition, we will do strategic hiring in our new department to make it a home for creative, rigorous metabolism scientists.”

ASBMB
Charles Brenner presents "Biochemistry and molecular biology education in a transforming academy and a molecular world" at the 2016 ASBMB annual meeting. Read our profile of him.
ASBMB Today Staff
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Related articles

Ceramides’ role in liver disease
Eleonora Scorletti & Rotonya M. Carr
Share your aha moments!
Allison Frick
Winners of the ‘aha moments’ essay contest
Richard F. Ludueña, Mindy Engevik & Kazuhiko Igarashi
ASBMB welcomes new members
ASBMB Today Staff

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Share your aha moments!
Editor's Note

Share your aha moments!

May 4, 2021

How a brainstorming session produced two videos, an essay contest and gratitude.

Winners of the ‘aha moments’ essay contest
Contest

Winners of the ‘aha moments’ essay contest

May 4, 2021

To celebrate our three journals going open access, we invited readers to share their moments of discovery in science. Here are the first, second and third place winners.

Stoddard wins mentoring award; Do honored as scholar–athlete
Member News

Stoddard wins mentoring award; Do honored as scholar–athlete

May 3, 2021

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

ASBMB welcomes new members
Member News

ASBMB welcomes new members

May 3, 2021

The American Society for Biochemistry and Molecular Biology welcomed more than 340 new members in January.

The 17th-century cloth merchant who discovered the vast realm of tiny microbes
News

The 17th-century cloth merchant who discovered the vast realm of tiny microbes

May 2, 2021

Although untrained in science, Antonie van Leeuwenhoek became the greatest lens-maker of his day, discovered microscopic life forms and is known today as the “father of microbiology.”

Meet Efraín E. Rivera–Serrano
Jobs

Meet Efraín E. Rivera–Serrano

April 30, 2021

Careers columnist Martina G. Efeyini talked to Efraín E. Rivera–Serrano to learn how he made the switch from having one academic job to having several science communication jobs.